![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 30, 27045-27052, July 26, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,
,
,
From the
Laboratory of Signal Transduction, NIEHS,
National Institutes of Health, Research Triangle Park, North
Carolina 27709, the § Membrane Biology Group, University of
Edinburgh, Edinburgh EH8 9XD, Scotland, and the ¶ Department
of Biochemistry, Purdue University, West Lafayette, Indiana 47907
Received for publication, April 1, 2002, and in revised form, May 10, 2002
| |
ABSTRACT |
|---|
|
|
|---|
We have investigated the structural basis for the
phenotype of a native rat Slo (rSlo) potassium channel
(BKCa; KCNMA1) in a rat pituitary cell line,
GH4C1. Opposing regulation of these calcium-
and voltage-activated potassium channels by cAMP- and cGMP-dependent protein kinases requires an alternatively
spliced exon (strex) of 59 amino acids in the cytoplasmic C terminus of the pore-forming Only one family of potassium channels (BKCa; KCNMA)
responds directly to both depolarization and intracellular calcium,
which allows them to integrate cellular excitability and provide
critical feedback inhibition (1-3). In mammalian tissues, a single
gene, slo (KCNMA1), encodes these big
conductance, Ca2+-activated potassium channels (4).
Nevertheless, the phenotype of BKCa channels varies widely
between tissues, between cells of the same tissue (5, 6), and in the
same cell types under different hormonal environments (7, 8). Several
factors that contribute individually to this diversity have been
identified, including alternative splicing (9, 10), regulatory We have previously characterized the regulation of native
BKCa channels by protein phosphorylation in a rat pituitary
cell line, GH4C1 (23-25). These channels are
stimulated by the cGMP-dependent protein kinase (PKG) and
inhibited by PKA, which is consistent with effects of hypothalamic
neuropeptides on pituitary cell excitability and secretion (26) and
with BKCa channel behavior in cell-free patches from
GH4C1 cells (27). However, to date no one has
reported a recombinant form of BKCa that displays all these
properties. Therefore, we believed it would be instructive to identify
the structural basis for BKCa regulation in the
GH4C1 cells. The data reveal new interactions
between the extracellular N terminus and the cytoplasmic C terminus of
the BKCa Cell Culture and Transfection--
HEK293 cells, a human
embryonic kidney cell line (ATCC CRL-1573), were cultured on glass
coverslips (Deutsche Spiegelglas, Carolina Biological) in Dulbecco's
modified Eagle's medium (H-21) supplemented with penicillin and
streptomycin and 10% fetal bovine serum (Hyclone). Channel constructs
in the pCI-neo vector were coexpressed transiently with a
plasmid-encoding green fluorescent protein (GFP) at a DNA ratio of 8:1
using LipofectAMINE 2000 (Invitrogen) as described by the manufacturer.
In less than 24 h, excised patches from weakly fluorescent cells
contained hundreds of BKCa channels. Stable cell lines for
single-channel recordings were generated by transfection of Ecr293
cells (Invitrogen), a HEK cell line stably expressing the ecdysone
receptor, with constructs in the ecdysone-inducible pIND vector
(Invitrogen) and selected in G418. When these cells were grown in the
absence of ecdysone, basal transcription from the plasmid was
sufficient to produce just enough channels for reliable single-channel
recording from excised patches of membrane. Native BKCa
channels were studied in GH4C1 cells, a rat
pituitary cell line, which were cultured in Ham's F-10 medium
supplemented with penicillin, streptomycin, 15% equine serum, 2.5%
fetal bovine serum, and 10 mg/liter phenol red as described previously
(27). It should be noted that GH4C1 cells cultured without phenol red had a much lower incidence of
BKCa modulation by PKA (19%, n = 3/16)
than cells in phenol red, which showed inhibition by PKA in 85% of
patches (n = 22/26).
Molecular Biology--
Both rSlo and
The strex insert was isolated from total GH4C1
cell RNA by RT-PCR using an anchored deoxyoligo (dT) primer
(5'-TTCTAgAATTCAgCggCCgC(T)30N1N2) and Superscript II reverse transcriptase (Invitrogen) for first-strand cDNA synthesis and forward (5'-gTC CTT CCC TAC TgT TTg) and reverse (5'-gTg TTT gAg CTC ATg ATA gT) PCR primers spanning splice site 2. Inserts containing rat strex were sequenced on both strands and
subcloned into unique BlpI and PacI restriction
sites of rSlo to give the rSlo-strex construct (Fig. 1). N-terminal
truncations ( Electrophysiology--
Slo channel currents were recorded in the
excised inside-out configuration using an EPC9 patch-clamp
amplifier/interface (HEKA) and an Apple Power Macintosh computer
running Pulse software (HEKA) for generation of pulses and data
acquisition. All experiments were performed at room temperature
(20-24 °C). Whenever BK channel modulators were applied to the
patch, the recording chamber (0.2 ml of effective volume) was perfused
with at least 10× the bath volume using a gravity-driven system at a
flow rate of 1-2 ml/min. Patch pipettes were manufactured from Corning
7052 glass with resistances of 2.5-4.5 M Reagents and Solutions--
Dehydrosoyasaponin-I was prepared as
a crude extract as published (28). ATP was added as the Mg-salt and
cyclic nucleotides cGMP and cAMP as Na-salts (Calbiochem). Okadaic
acid, PKG (recombinant bovine isoform I
For cell-free recordings from excised inside-out patches of membrane,
the patch pipette, which contacts the extracellular side of the
membrane, contained either physiological saline (in mM):
135, NaCl; 10 HEPES; 1, MgCl2; 0.1, CaCl2 with
the pH adjusted to 7.4 with NaOH, or symmetrical
K+ solution (in mM): 135, KCl; 10, HEPES; 1, MgCl2; 0.1, CaCl2 with the
pH adjusted to 7.4 with KOH. The standard bath solution for the former
cytoplasmic side of the patch was (in mM): 145, KCl; 20, HEPES; 1, MgCl2; and 0.1, dithiothreitol with the pH
adjusted to 7.4 with KOH. Bath solutions were passed over a Chelex 100 (Bio-Rad) ion-exchange column, prior to adding Ca2+ buffers
and divalent ions in order to remove potential metal contaminants. To
buffer calcium reliably without saturation at physiological
concentrations between 0.1 and 10 µM, we used the Mg- and
pH-insensitive buffer, BAPTA, and its lower affinity dibromo derivative
(Molecular Probes). Free Ca2+ concentrations were
calculated with WinMAXC (www.stanford.edu/~spatton/maxc.html). The
actual free Ca2+ concentrations were independently verified
with a calcium electrode (Orion, Model 97-20 ionoplus), which was
calibrated with buffered calcium solutions (Molecular Probes, Buffer
kit 2 with 1 mM Mg).
Data Analysis--
Single-channel open probability
(Po) was derived either from single-channel analysis using
TAC and TACFit (Bruxton) for patches with 1-3 channels, or in the case
of patches with 4-15 channels, by the integration-over-baseline
technique using Igor Pro (WaveMetrix). In the latter case
N*Po values were determined as follows. All-point histograms were plotted to obtain the offset, i.e. leak
current, as well as the single-channel current amplitude from the peak intervals. After subtraction of the offset from the traces these were
integrated over 10-60-s segments. The integral divided by integration
time and single-channel current amplitude gives N*Po. Statistical significance of differences between treatments was evaluated using an unpaired Student's t test on the
N*Po or Po averages obtained from several
minutes of recordings. The voltage-dependence of Slo currents was
either measured from Po versus membrane
potential plots (patches with 1-3 channels), or in the case of patches
with macroscopic currents, from normalized plots of the tail currents recorded in symmetrical K+ solution at The BKCa
subunit encoded by rslo.
However, inclusion of this cysteine-rich exon produces a 10-fold
increase in the sensitivity of the channels to inhibition by oxidation.
Inclusion of the strex exon also increases channel sensitivity to
stimulation by calcium, but responses in the physiological ranges of
calcium and voltage require coassembly with
1 subunits.
With strex present, however,
1 subunits only stimulated
channels assembled from rSlo
subunits with a truncated N terminus
beginning MDALI- . Thus N-terminal variation and strex exon
splicing in rSlo interact to produce BKCa channels with a
physiologically relevant phenotype.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunits (11, 12), and protein phosphorylation (13, 14), but the influence of these factors on one another has not been studied in
detail. For example, most recombinant forms of BKCa
channels are stimulated by the cAMP-dependent protein
kinase (PKA)1 (15), but the
response of BKCa channels to PKA in a mouse pituitary cell
line, AtT20 (16, 17), is reversed by insertion of a 59-amino acid exon
(strex) at splice site 2 in the C terminus (18). However, most studies
of recombinant BKCa channel regulation by protein phosphorylation have employed a cDNA that begins at the third potential initiator methionine (MDALI-) encoded by the slo
gene (19), omitting up to 65 amino acids in the N terminus. Because this extracellular N-terminal sequence of the pore-forming
subunit interacts with the
subunit (20), which also increases calcium sensitivity, we postulated that these structural changes might interact
with one another. In addition, we wondered whether some of the
variability in the regulation of BKCa channels by exogenous protein kinases might result from nonspecific effects associated with
stimulation of the channel by the sulfhydryl reducing agents (21, 22),
which are routinely included in purified preparations of the enzymes.
subunit with potential physiological
significance for channel regulation by calcium, oxidation, and phosphorylation.
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 subunits
of the BKCa channel were cloned by RT-PCR from total
GH4C1 cell RNA using primers based on the
GenBankTM sequences U55995 isolated from adult female rat myometrium and U79661 from rat cerebral vascular smooth muscle. An
EcoRI-MluI oligonucleotide adapter designed to
encode an N-terminal FLAG epitope with a short linker region
(MVDYKDDDKLGGGATR) was inserted into a multiple cloning site of pCI
(Promega) to generate pCI-FLAG. The forward primer covered U55995
nucleotides 64-87 (5'-ATG AGC AAT ATC CAC GCG AAC CAT), whereas the
reverse primer was from nucleotides 3574-3597 (the reverse complement
of 5'-CCA GAA ACA TTC AAA TCA AGC CCA taaagcggccgc) and included a TAA
stop codon and NotI cloning site. An endogenous
MluI site (position 98 in U55995) was used as the 5'-cloning
site for the PCR product. This necessitated the insertion of an adapter
oligonucleotide sequence between the MluI site in the
pCI-FLAG vector and the internal rSlo MluI site to encode
the N-terminal 12 amino acids of the mature peptide reported in U55995.
The resulting clone expressed rSlo-FLAG. The N-terminal FLAG sequences
were removed from rSlo-FLAG by swapping out an
EcoRI-MluI fragment with the oligonucleotide
sequence 5'-GAA TTC CCC ATG AGC AAT ATC CAC GCG AAC CAT CTC AGC CTA GAC
GCG T-3' to generate rSlo. Five full-length clones of the rSlo
subunit were isolated independently in separate PCR reactions and
sequenced on both strands. All clones contained identical N and C
termini (Fig. 1) with no inserts at known
sites of alternative splicing. The GH4C1 clone
of rSlo is identical to the rat smooth muscle sequence (U55995) up to
Gln-1140, but then it encodes only seven additional amino acids before
terminating in a stop codon.

View larger version (32K):
[in a new window]
Fig. 1.
Primary structure of rSlo isolated from
GH4C1 cells. A, N-terminal
alignment of rSlo with slo gene products isolated from rat
smooth muscle (U55995) and human brain (U11717). B, the C
terminus of the same clones indicating putative phosphorylation sites
for PKG (15) and PKC (36). C, the strex exon of 59 amino
acids that is inserted at Leu-668 and contains a putative
phosphorylation site for PKA (17). D, diagram of
rSlo topology and the variants used in this study.
N) of both rSlo and rSlo-strex were generated by
site-directed mutagenesis of the initiator methionine (MSNIH-) to
alanine, forcing transcription to begin at the next potential
initiator methionine, MDALI- (Fig. 1).
for single-channel
recordings and 1.5-2.5 M
for pipettes used to record macroscopic
currents from patches with high channel densities. To minimize series
resistance errors, the access resistance was partially compensated
(~60%), and analysis was limited to patches with currents
3 nA at
150 mV.
), and the PKA inhibitor
(6-22 amide) were obtained from Calbiochem, and the PKA catalytic
subunit from Biolab. An anti-FLAG monoclonal antibody (M2, F-3165) was
purchased from Sigma. Unfixed cells were stained in complete medium
with serum for 20 min, washed 3× with complete medium, and exposed to
1 µg/ml of a second antibody, Alexa FluorÆ488 goat anti-mouse IgG
(Molecular Probes), in complete medium for 15 min.
70 mV. Plots of
Po or normalized tail current amplitudes were fitted with a
Boltzmann curve and the voltage of half-maximal activation
(V1/2), derived from 1/(1 + exp(Vm
V1/2)/k).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
subunit channel protein encoded by the
rSlo cDNA isolated from GH4C1 RNA (Fig. 1)
is identical to the rat smooth muscle sequence (U55995) up to Gln-1140
and almost as similar to clones from mouse and human brain (29, 30).
The GH4C1 rSlo cDNA was expressed
efficiently in HEK293 cells and produced robust currents activated by
depolarization and cytoplasmic calcium (Fig. 2). Expression of the entire cDNA was
confirmed by addition of a FLAG epitope to the N terminus (see
"Experimental Procedures"), which was detected immunologically at
the surface of intact cells (Fig. 2A), as predicted (31).
Excised patches of membrane expressing rSlo produced currents in the
nanoampere range (Fig. 2B), corresponding to hundreds of
functional BKCa channels in each square micrometer of
membrane. With or without the FLAG epitope, the channels in such
patches showed relative sensitivities to depolarization and cytoplasmic
calcium (Fig. 2C) comparable to native channels from GH4C1 cells (27). Thus, on average, 17-mV
depolarization produced an e-fold increase in activity at any fixed
calcium. Similarly a 10-fold increase in the calcium concentration at
the cytoplasmic surface shifted the voltage required for half-maximal
stimulation by 50 mV toward more negative potentials. However, the
absolute sensitivity of the channels to calcium was 10-fold lower than native channels, which are stimulated half-maximally by 1 µM calcium at approximately +20 mV (27).

View larger version (24K):
[in a new window]
Fig. 2.
The rSlo gene encodes a functional
BKCa channel. A, confocal image shows
surface staining with anti-FLAG antibody of intact HEK293 cells
expressing rSlo with a FLAG tag at the N terminus. B,
currents recorded from excised, inside-out patches of HEK293 cells,
which had been transfected the night before with FLAG-tagged rSlo.
Recording in symmetrical potassium solution; voltage protocol
illustrated under the current traces. C, plots of
normalized, quasi-macroscopic currents (G/Gmax)
as a function of the step potential from tail currents at
70 mV show
the voltage and calcium dependence of rSlo currents (without the FLAG
tag).
The rSlo channels also differed from native BKCa channels
in GH4C1 cells by their response to adenine
nucleotides on the cytoplasmic side of the patch (Fig.
3). In patches from
GH4C1 cells, addition of Mg-ATP inhibits
channel activity through protein phosphorylation by PKA (27), which is
reversed by a peptide inhibitor of PKA (Fig. 3A;
n = 5 patches). In contrast, rSlo inhibition by 0.5 mM ATP in patches from HEK293 cells is not blocked by the
PKA inhibitor peptide (n = 0/3) and is mimicked by a
nonhydrolysable analogue of ATP (AMP-PNP) (Fig. 3B,
n = 4/4). This direct inhibitory effect of adenine
nucleotides on recombinant BKCa channels is similar to the
effect reported previously on a cDNA from mouse brain, mb2 (32),
which has identical N and C termini as the rSlo cDNA from
GH4C1 cells (29). As reported by Clark et
al. (32) for mb2 channels, coexpression with the
1
subunit eliminated the direct effect of ATP on the channels (Fig.
3C), but the rSlo channels remained insensitive to
regulation by PKA, showing neither inhibition nor stimulation, even in
the presence of 1 µM okadaic acid to inhibit endogenous
protein phosphatases (Fig. 3C, n = 0/10).
|
The Strex Exon Partially Restores the Native Phenotype to rSlo
Channels--
Previous studies of BKCa channels in a mouse
pituitary cell line AtT20 (16) have identified a 59-amino acid exon,
strex, in the C terminus near the calcium-binding site (Fig. 1,
C and D), which is required for BKCa
channel inhibition by PKA (17). Expression of rSlo with the strex exon
inserted in place of L668 (rSlo-strex) in HEK cells produced
BKCa channels that were inhibited by PKA (Fig.
4). Even in patches with
quasi-macroscopic currents, addition of ATP and cAMP reduced the
activity of all the channels, increasing the voltage required to
produce half-maximal activity by +20 mV (Fig. 4A), which is
quantitatively very similar to the effect of PKA on native
BKCa channels in GH4C1 cells (27).
At the single-channel level, ATP/cAMP reduced activity in 86% of the
patches (n = 12/14) producing on average a 49%
decrease (Fig. 4B). Unlike the effect of ATP on rSlo
channels, inhibition of rSlo-strex channels by ATP/cAMP was reversed by
a peptide inhibitor of PKA, PKA-I, which increased channel activity in
the presence of ATP/cAMP by 67% on average (n = 6, Fig. 4C). Thus, endogenous PKA and phosphatase molecules
appear to be associated closely with the BKCa channel in
cell-free patches of membrane.
|
Inclusion of the strex exon also increased the sensitivity of
recombinant BKCa channels to inhibition by oxidation (Fig.
5). Native BKCa channels in
GH4C1 cells showed a wide range of sensitivity to oxidation (Fig. 5C), which was measured by replacing 1 mM dithiothreitol with 0.1 mM thimerosal (22).
Some native channels were inhibited 2-3-fold by thimerosal (Fig.
5A), whereas other native BKCa channels were
much more sensitive to inhibition (Fig. 5B). Recombinant rSlo channels in HEK cells were uniformly less sensitive to inhibition by oxidation (Fig. 5C), which is comparable to the
sensitivity reported previously for other recombinant channels (22).
However, rSlo-strex channels were an order of magnitude more sensitive to inhibition by thimerosal (Fig. 5C). Although thimerosal
inhibited the activity of rSlo channels to 40% of their control
activity in dithiothreitol (n = 7), the same
concentration of thimerosal inhibited 95% of the activity of
rSlo-strex channels (n = 6). The increased sensitivity
of rSlo-strex channels to inhibition by oxidation is consistent with
the high cysteine content of the strex exon (18), and provides
additional evidence that native BKCa channels in
GH4C1 cells, like the BKCa channels
in mouse pituitary cells (16), also contain the strex exon.
Nevertheless, rSlo-strex channels also differed from the native
channels in GH4C1 cells in one essential
feature; their absolute sensitivity to stimulation by calcium.
|
rSlo-strex Is Insensitive to Physiological Calcium--
Although
inclusion of the strex exon shifted the calcium sensitivity of rSlo by
~20 mV toward more negative potentials (Fig. 6), as reported previously for other
recombinant channels (8, 18), membrane potentials more positive than
+75 mV were required to produce half-maximal activation of rSlo-strex
in 2 µM calcium (Fig. 6A). In contrast,
half-maximal activation of native BKCa channels under
similar conditions occurs at voltages around +20 mV (27), which are
routinely observed during spontaneous spiking. Surprisingly,
coexpression of the rat
1 subunit from
GH4C1 cells did not alter the calcium
sensitivity of rSlo-strex (Fig. 6A) even though
1 did alter the kinetics of gating (Fig. 6B)
and the sensitivity to stimulation by dehydrosoyasaponin-I (Fig.
6C), indicating efficient expression of
1 and
interaction with the
subunit (33). The insensitivity to calcium was
also not an artifact of the HEK cell expression system. Mutation of
tyrosine 294 to valine at the external mouth of the pore (34)
eliminated the sensitivity of rSlo-strex to inhibition by external
tetraethylammonium (not shown) and allowed us to study its calcium
sensitivity in GH4C1 cells without
contamination by native channels. Nevertheless, Y294V-strex channels in
GH4C1 cells were just as insensitive to calcium
as rSlo-strex channels in HEK293 cells (Fig. 6A).
|
rSlo
N-strex Behaves Like the Native BKCa Channel in
GH4C1 Cells--
In other studies of
recombinant BKCa channels (33, 35), the
1
subunit is highly effective at increasing calcium sensitivity, shifting
the voltage required for half-maximal activation at a given
concentration of calcium toward more negative potentials by 50 mV or
more. Because many of the studies used clones that began MDALI- in the
N terminus, we also expressed truncated forms of rSlo and rSlo-strex
that began at MDALI, which we labeled rSlo
N and rSlo
N-strex,
respectively (Fig. 1). The calcium sensitivity of rSlo
N is slightly
higher than rSlo (Fig. 7A),
but strex inclusion at splice site 2 in rSlo
N shifted the voltage
required for half-maximal activation toward more negative potentials by
>40 mV (Fig. 7A). In addition, coexpression of
1 shifted rSlo
N-strex by a further 25 mV toward more
negative voltages (Fig. 7A). Thus, the absolute calcium
sensitivity of rSlo
N-strex is very similar to native BKCa channels in GH4C1 cells.
Furthermore, rSlo
N-strex retains the native property of simultaneous
sensitivity to inhibition by PKA and stimulation by PKG (Fig. 7,
B and C). On average, cAMP-dependent phosphorylation inhibited rSlo
N-strex channel activity by 45.5% (n = 8), whereas cGMP-dependent
phosphorylation stimulated activity in 13 of 20 patches by 89%. In
both cases, regulation was mediated by endogenous protein kinases,
which remained associated with the channels in cell-free patches of
membrane.
|
| |
DISCUSSION |
|---|
|
|
|---|
The big-conductance, calcium- and voltage-activated potassium
channels BKCa encoded by the slo gene
(KCNMA1) play a powerful integrative role in the regulation
of electrical excitability in many tissues, so it is not surprising
that they are also regulated by a complex network of signal
transduction pathways. Many of these regulatory mechanisms have been
identified, but this is the first study that specifically investigates
the interactions between them on recombinant channels. We previously
characterized the regulation of native BKCa channels by
reversible protein phosphorylation in a rat pituitary cell line,
GH4C1 (23-25, 27). In this study we have
identified a structural variant of the rSlo gene product, rSlo
N-strex (Fig. 1), which recapitulates that regulation (Fig. 7).
Furthermore, when it is coexpressed with
1 subunits,
rSlo
N-strex is just as sensitive to calcium as native channels (Fig.
7). The requirement of strex inclusion in Slo channels for inhibition by PKA has been observed previously in murine BKCa channels
cloned from a mouse pituitary cell line (16), where it was shown that PKA produces inhibition by phosphorylating a serine in the strex exon
(17). Without strex, however, we never observed stimulation of rSlo by
PKA, unlike many other recombinant forms of the BKCa channel (15, 17, 36). We have not ruled out the possibility that
background PKC-dependent phosphorylation of our clone
occludes its stimulation by PKA as reported for a full-length bovine
Slo channel (36). However, unlike the bovine Slo construct, our rSlo
N-strex construct can be simultaneously inhibited by PKA and
stimulated by PKG (Fig. 7), as reported previously for native channels
from GH4C1 cells (24).
In designing our experimental solutions, we took four uncommon
precautions to ensure reproducible recordings of physiological significance. All pipette solutions were passed over an ion-exchange column to remove potential metal contaminants prior to adding divalent
ions. Metal ions are known to block BKCa channel pores, particularly at strongly depolarized membrane potentials, where they
might artificially reduce estimates of Gmax. To maintain the activity of kinases and phosphatases associated with the cell-free patches, we added 1 mM Mg2+ and 0.1 mM dithiothreitol to all the solutions that bathed the former cytoplasmic side of the cell-free patches. In addition ATP was
always added as a magnesium salt, so free Mg2+, which has
direct effects on BKCa gating (37, 38), remained constant.
To buffer calcium reliably without saturation at physiological concentrations between 0.1 and 10 µM, we used the Mg- and
pH-insensitive buffer, BAPTA, and its lower affinity dibromo derivative
(39). With these precautions we have also identified two novel
properties of BKCa regulation of potential physiological
significance: the effect of N-terminal variation on interactions with
the
subunit and the unusually high sensitivity of the strex form to
inhibition by oxidation.
There have been very few studies of recombinant BKCa
channels that begin at the first methionine encoded by the
slo gene (19, 40), and this is the first study to
specifically compare the behavior of channels with different initiator
methionines under identical experimental conditions. Such a study is
important because the initiation site for translation has not been
identified unambiguously for any native BKCa channel, and
there are no antibodies available to distinguish N-terminal variations
in native BKCa channels at the cell surface. The rSlo
constructs beginning MSNIH- produce BKCa channels with the
same relative sensitivity to calcium, but a much lower absolute
sensitivity than native BKCa channels in GH4C1 cells (27). This difference cannot be
attributed to the longer N-terminal sequence because the rSlo
N
construct beginning MDALI- produces channels with very similar
sensitivity as rSlo channels (Fig. 7) and other recombinant Slo
channels (29, 30). The rSlo construct from
GH4C1 cells also differs from native channels in that the channels are inhibited directly by ATP at concentrations that are predicted to occur in vivo (Fig. 3). This effect
does not involve protein phosphorylation because it is also produced by
AMP-PNP, a nonhydrolysable analogue of ATP. A similar
phosphorylation-independent effect of ATP on a BKCa clone
from mouse brain, mb2 (29), with identical N and C termini has been
reported previously (32). Other Slo constructs, such as mbr5 (41) with
different N and/or C termini do not show such inhibition by ATP (32).
Coexpression of the
1 subunit with rSlo prevents direct
inhibition by ATP (not shown) and increases their sensitivity to
calcium (see below), as reported for mb2 (32, 33). However, based on
their low sensitivity to calcium and their inhibition by physiological
concentrations of ATP, it is unlikely that BKCa channels
comprised solely of rSlo
subunits from
GH4C1 cells contribute much current under normal conditions. In ischemic conditions however, with calcium rising
and ATP falling, the rSlo subunits might provide a reservoir of
emergency K+ channels that could limit further excitotoxicity.
The calcium sensitivity of other recombinant Slo channels is increased
by several factors, including alternative mRNA splicing (8, 18),
subunits (19, 33, 40), and protein phosphorylation (14). The
calcium sensitivity of BKCa channels encoded by the rSlo
cDNA from GH4C1 cells is also increased by
inclusion of the strex exon (8) at splice site 2 (Leu-668 in rSlo) near
the calcium-binding site in the cytoplasmic C terminus of the protein (Figs. 1 and 6). The strex exon was originally identified as a cysteine-rich insert at splice site 2 in BKCa channels from
chromaffin and pituitary cells, which increased the channels'
sensitivity to stimulation by calcium (18). Subsequently, the strex
exon was shown to determine the response of BKCa channels
in mouse pituitary AtT20 cells to protein phosphorylation by the
cAMP-dependent protein kinase (16, 17). Inclusion of the
strex exon in rSlo from rat pituitary GH4C1
cells also produced BKCa channels that were inhibited by
PKA (Fig. 4), like the native channels from those cells (23, 27).
However, strex inclusion in rSlo had two additional effects of
potential physiological significance, which have not been described before.
Firstly, strex inclusion in rSlo makes the resulting BKCa channels extremely vulnerable to inhibition by oxidation. For example, the activity of fully reduced channels in dithiothreitol, which is presumed to be comparable to the redox conditions in vivo, is inhibited greater than 95% by exposure to chemical oxidants such as thimerosal (Fig. 3). In contrast recombinant Slo channels without strex are inhibited less than 50% by exposure to comparable oxidants (21, 22). Expressed as a fold reduction in activity, strex-containing channels are 10× more sensitive to oxidation.
Secondly, we discovered that the incorporation of strex near the
calcium-binding site in the C terminus (Fig. 1) alters the effectiveness of the
1 subunit at increasing calcium
sensitivity, and this effect depends on the sequence at the
extracellular N terminus of rSlo that interacts with
1
(20).
1 subunits have been reported to produce large
increases in the calcium sensitivity of many recombinant forms of Slo
(19, 33, 40), although the effectiveness of the
subunit varies with
the absolute calcium concentration, becoming less effective at
concentrations in the physiological range near 1 µM and
below (35, 42). For example, the
1 subunit that we
isolated from GH4C1 cells increased the activity of both our rSlo and rSlo-strex channels at calcium
concentrations >100 µM (not shown), but the
1 subunit did not stimulate either rSlo or rSlo-strex
channels in the physiological range of 1-10 µM calcium
(Fig. 6). We confirmed that the
1 subunits interact with
both rSlo and rSlo-strex channels under these conditions because the
currents had slower kinetics and channels were stimulated by
dehydrosoyasaponin when the
1 subunits were expressed
(Fig. 6). In contrast, inclusion of strex in the truncated rSlo
N
channels that start at MDALI- extends the effectiveness of
1 on calcium sensitivity to calcium concentrations in
the physiological range (Fig. 7), making rSlo
N-strex as sensitive to
calcium as native channels in GH4C1 cells.
Thus, the polyserine domain between the first and second methionines of
rSlo (Fig. 1) inhibits the ability of
1 subunits to
alter calcium sensitivity, which is consistent with the evidence that
the transmembrane
1 subunit interacts with Slo channels
at their extracellular N terminus (20). Consequently, the regulation of
BKCa structure through alternative splicing of rSlo by
hormones (8, 10) and activity-generated calcium transients (43) could
have dramatic effects on endocrine excitability in the pituitary
(44).
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Laboratory of
Signal Transduction (F2-05), NIEHS, National Institutes of
Health, 111 Alexander Dr., Research Triangle Park, NC 27709. Tel.: 919-541-0062; E-mail: armstro3@niehs.nih.gov.
Published, JBC Papers in Press, May 16, 2002, DOI 10.1074/jbc.M203087200
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
PKA, cAMP-dependent protein kinase;
PKG, cGMP-dependent protein kinase;
r, rat;
HEK, human embryonic
kidney;
N, N-terminal truncations;
BAPTA, 1,2-bis-(2-aminophenoxy)ethane-N,N,N,N-tetraacetate;
AMP-PNP, adenosine 5'-(
,
-imino)triphosphate.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Wei, A., Solaro, C., Lingle, C., and Salkoff, L. (1994) Neuron 13, 671-681[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Robitaille, R., and Charlton, M. P. (1992) J. Neurosci. 12, 297-305[Abstract] |
| 3. | Wang, Z. W., Saifee, O., Nonet, M. L., and Salkoff, L. (2001) Neuron 32, 867-881[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Atkinson, N. S.,
Robertson, G. A.,
and Ganetzky, B.
(1991)
Science
253,
551-555 |
| 5. | Navaratnam, D. S., Bell, T. J., Tu, T. D., Cohen, E. L., and Oberholtzer, J. C. (1997) Neuron 19, 1077-1085[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Rosenblatt, K. P., Sun, Z. P., Heller, S., and Hudspeth, A. J. (1997) Neuron 19, 1061-1075[CrossRef][Medline] [Order article via Infotrieve] |
| 7. |
Perez, G.,
and Toro, L.
(1994)
Am. J. Physiol.
266,
C1459-C1463 |
| 8. |
Xie, J.,
and McCobb, D. P.
(1998)
Science
280,
443-446 |
| 9. | Adelman, J. P., Shen, K. Z., Kavanaugh, M. P., Warren, R. A., Wu, Y. N., Lagrutta, A., Bond, C. T., and North, R. A. (1992) Neuron 9, 209-216[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Shipston, M. J. (2001) Trends Cell Biol. 11, 353-358[CrossRef][Medline] [Order article via Infotrieve] |
| 11. |
Knaus, H. G.,
Garcia-Calvo, M.,
Kaczorowski, G. J.,
and Garcia, M. L.
(1994)
J. Biol. Chem.
269,
3921-3924 |
| 12. |
Brenner, R.,
Jegla, T. J.,
Wickenden, A.,
Liu, Y.,
and Aldrich, R. W.
(2000)
J. Biol. Chem.
275,
6453-6461 |
| 13. | Reinhart, P. H., Chung, S., Martin, B. L., Brautigan, D. L., and Levitan, I. B. (1991) J. Neurosci. 11, 1627-1635[Abstract] |
| 14. | Schubert, R., and Nelson, M. T. (2001) Trends Pharmacol. Sci. 22, 505-512[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Nara, M.,
Dhulipala, P. D.,
Wang, Y. X.,
and Kotlikoff, M. I.
(1998)
J. Biol. Chem.
273,
14920-14924 |
| 16. |
Shipston, M. J.,
Duncan, R. R.,
Clark, A. G.,
Antoni, F. A.,
and Tian, L.
(1999)
Mol. Endocrinol.
13,
1728-1737 |
| 17. |
Tian, L.,
Duncan, R. R.,
Hammond, M. S.,
Coghill, L. S.,
Wen, H.,
Rusinova, R.,
Clark, A. G.,
Levitan, I. B.,
and Shipston, M. J.
(2001)
J. Biol. Chem.
276,
7717-7720 |
| 18. |
Saito, M.,
Nelson, C.,
Salkoff, L.,
and Lingle, C. J.
(1997)
J. Biol. Chem.
272,
11710-11717 |
| 19. |
McCobb, D. P.,
Fowler, N. L.,
Featherstone, T.,
Lingle, C. J.,
Saito, M.,
Krause, J. E.,
and Salkoff, L.
(1995)
Am. J. Physiol.
269,
H767-H777 |
| 20. |
Wallner, M.,
Meera, P.,
and Toro, L.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
14922-14927 |
| 21. |
DiChiara, T. J.,
and Reinhart, P. H.
(1997)
J. Neurosci.
17,
4942-4955 |
| 22. |
Wang, Z. W.,
Nara, M.,
Wang, Y. X.,
and Kotlikoff, M. I.
(1997)
J. Gen. Physiol.
110,
35-44 |
| 23. | White, R. E., Schonbrunn, A., and Armstrong, D. L. (1991) Nature 351, 570-573[CrossRef][Medline] [Order article via Infotrieve] |
| 24. | White, R. E., Lee, A. B., Shcherbatko, A. D., Lincoln, T. M., Schonbrunn, A., and Armstrong, D. L. (1993) Nature 361, 263-266[CrossRef][Medline] [Order article via Infotrieve] |
| 25. | Shipston, M. J., and Armstrong, D. L. (1996) J. Physiol. 493, 665-672[Medline] [Order article via Infotrieve] |
| 26. |
Lamberts, S. W.,
and Macleod, R. M.
(1990)
Physiol. Rev.
70,
279-318 |
| 27. |
Hall, S. K.,
and Armstrong, D. L.
(2000)
J. Biol. Chem.
275,
3749-3754 |
| 28. | McManus, O. B., Harris, G. H., Giangiacomo, K. M., Feigenbaum, P., Reuben, J. P., Addy, M. E., Burka, J. F., Kaczorowski, G. J., and Garcia, M. L. (1993) Biochemistry 32, 6128-6133[CrossRef][Medline] [Order article via Infotrieve] |
| 29. |
Pallanck, L.,
and Ganetzky, B.
(1994)
Hum. Mol. Genet.
3,
1239-1243 |
| 30. | Tseng-Crank, J., Foster, C. D., Krause, J. D., Mertz, R., Godinot, N., DiChiara, T. J., and Reinhart, P. H. (1994) Neuron 13, 1315-1330[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Meera, P.,
Wallner, M.,
Song, M.,
and Toro, L.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
14066-14071 |
| 32. |
Clark, A. G.,
Hall, S. K.,
and Shipston, M. J.
(1999)
J. Physiol.
516,
45-53 |
| 33. | McManus, O. B., Helms, L. M., Pallanck, L., Ganetzky, B., Swanson, R., and Leonard, R. J. (1995) Neuron 14, 645-650[CrossRef][Medline] [Order article via Infotrieve] |
| 34. | Shen, K. Z., Lagrutta, A., Davies, N. W., Standen, N. B., Adelman, J. P., and North, R. A. (1994) Pflugers Arch. 426, 440-445[CrossRef][Medline] [Order article via Infotrieve] |
| 35. |
Cox, D. H.,
and Aldrich, R. W.
(2000)
J. Gen. Physiol.
116,
411-432 |
| 36. |
Zhou, X. B.,
Arntz, C.,
Kamm, S.,
Motejlek, K.,
Sausbier, U.,
Wang, G. X.,
Ruth, P.,
and Korth, M.
(2001)
J. Biol. Chem.
276,
43239-43245 |
| 37. |
Shi, J.,
and Cui, J.
(2001)
J. Gen. Physiol.
118,
589-606 |
| 38. |
Zhang, X.,
Solaro, C. R.,
and Lingle, C. J.
(2001)
J. Gen. Physiol.
118,
607-636 |
| 39. | Tsien, R. Y. (1980) Biochemistry 19, 2396-2404[CrossRef][Medline] [Order article via Infotrieve] |
| 40. | Wallner, M., Meera, P., Ottolia, M., Kaczorowski, G. J., Latorre, R., Garcia, M. L., Stefani, E., and Toro, L. (1995) Recept. Channels 3, 185-199[Medline] [Order article via Infotrieve] |
| 41. |
Butler, A.,
Tsunoda, S.,
McCobb, D. P.,
Wei, A.,
and Salkoff, L.
(1993)
Science
261,
221-224 |
| 42. | Meera, P., Wallner, M., Jiang, Z., and Toro, L. (1996) FEBS Lett. 382, 84-88[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Xie, J., and Black, D. L. (2001) Nature 410, 936-939[CrossRef][Medline] [Order article via Infotrieve] |
| 44. |
van Goor, F., Li, Y. X.,
and Stojilkovic, S. S.
(2001)
J. Neurosci.
21,
5902-5915 |
This article has been cited by other articles:
![]() |
B. Wang and R. Brenner An S6 Mutation in BK Channels Reveals {beta}1 Subunit Effects on Intrinsic and Voltage-dependent Gating J. Gen. Physiol., December 1, 2006; 128(6): 731 - 744. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Semenov, B. Wang, J. T. Herlihy, and R. Brenner BK channel beta1-subunit regulation of calcium handling and constriction in tracheal smooth muscle Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L802 - L810. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-J. Lai and D. P. McCobb Regulation of Alternative Splicing of Slo K+ Channels in Adrenal and Pituitary during the Stress-Hyporesponsive Period of Rat Development Endocrinology, August 1, 2006; 147(8): 3961 - 3967. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sade, K. Muraki, S. Ohya, N. Hatano, and Y. Imaizumi Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids Am J Physiol Cell Physiol, January 1, 2006; 290(1): C77 - C86. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. McCartney, H. McClafferty, J.-M. Huibant, E. G. Rowan, M. J. Shipston, and I. C. M |